Insider Trading
AORT Stock Insider Trading Activity
Track Major Insider Updates On TwitterCorporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on AORT stock insider trading activity, which can give hints on whether executives are bullish or bearish on their own company.
Recent insider purchases and sales - AORT
| Name / Title | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
|
Holloway Jean F
SVP, General Counsel
|
Sale | 3167 | Aug 26, 2024 | Aug. 27, 2024, 4:47 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 2562 | Aug 16, 2024 | Aug. 19, 2024, 4:58 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 6858 | Aug 16, 2024 | Aug. 19, 2024, 4:58 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2383 | Aug 15, 2024 | Aug. 16, 2024, 11:38 a.m. |
|
SEMEDO ANTHONY B.
|
Sale | 9709 | Aug 13, 2024 | Aug. 15, 2024, 10:37 a.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1250 | May 10, 2024 | May 13, 2024, 6:05 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 979 | May 09, 2024 | May 10, 2024, 5:12 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 2183 | Mar 20, 2024 | March 21, 2024, 5:14 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 1462 | Mar 15, 2024 | March 18, 2024, 6:09 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 3994 | Mar 14, 2024 | March 15, 2024, 5:20 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 5000 | Mar 12, 2024 | March 14, 2024, 9:06 p.m. |
|
Mackin James P
President & CEO
|
Sale | 13996 | Mar 05, 2024 | March 7, 2024, 7:20 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 2380 | Mar 05, 2024 | March 7, 2024, 7:16 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2022 | Mar 05, 2024 | March 7, 2024, 7:14 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 1157 | Mar 05, 2024 | March 7, 2024, 7:12 p.m. |
|
Maney Rochelle L.
VP, Quality
|
Sale | 1157 | Mar 05, 2024 | March 7, 2024, 7:10 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 1160 | Mar 05, 2024 | March 7, 2024, 7:07 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 1506 | Mar 05, 2024 | March 7, 2024, 7:05 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 1152 | Mar 05, 2024 | March 7, 2024, 7:01 p.m. |
|
Tyrs Florian
VP, Global Operations
|
Sale | 339 | Feb 27, 2024 | Feb. 29, 2024, 6:43 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 325 | Feb 27, 2024 | Feb. 29, 2024, 6:39 p.m. |
|
Mackin James P
President & CEO
|
Sale | 4837 | Feb 27, 2024 | Feb. 29, 2024, 6:36 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 485 | Feb 27, 2024 | Feb. 29, 2024, 6:34 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 584 | Feb 27, 2024 | Feb. 29, 2024, 6:32 p.m. |
|
Maney Rochelle L.
VP, Quality
|
Sale | 370 | Feb 27, 2024 | Feb. 29, 2024, 6:30 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 325 | Feb 27, 2024 | Feb. 29, 2024, 6:27 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 421 | Feb 27, 2024 | Feb. 29, 2024, 6:21 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 465 | Feb 27, 2024 | Feb. 29, 2024, 6:18 p.m. |
|
Mackin James P
President & CEO
|
Sale | 13168 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
Mackin James P
President & CEO
|
Sale | 18144 | Feb 26, 2024 | Feb. 28, 2024, 6:22 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1314 | Feb 26, 2024 | Feb. 28, 2024, 6:18 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1566 | Feb 26, 2024 | Feb. 28, 2024, 6:18 p.m. |
|
Maney Rochelle L.
VP, Quality
|
Sale | 1185 | Feb 26, 2024 | Feb. 28, 2024, 6:16 p.m. |
|
Maney Rochelle L.
VP, Quality
|
Sale | 1130 | Feb 26, 2024 | Feb. 28, 2024, 6:16 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 1185 | Feb 26, 2024 | Feb. 28, 2024, 6:07 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 1128 | Feb 26, 2024 | Feb. 28, 2024, 6:07 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 1218 | Feb 26, 2024 | Feb. 28, 2024, 6:04 p.m. |
|
GREEN ANDREW M
VP Regulatory
|
Sale | 1185 | Feb 26, 2024 | Feb. 28, 2024, 6:04 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 1600 | Feb 26, 2024 | Feb. 28, 2024, 6:02 p.m. |
|
Stanton Marshall S.
SVP, Clinical & MD Affair
|
Sale | 1448 | Feb 26, 2024 | Feb. 28, 2024, 6:02 p.m. |
|
Tyrs Florian
VP, Global Operations
|
Sale | 893 | Feb 26, 2024 | Feb. 28, 2024, 5:58 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1871 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 1192 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
|
Holloway Jean F
SVP, General Counsel
|
Sale | 464 | Feb 20, 2024 | Feb. 22, 2024, 6:37 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 366 | Feb 20, 2024 | Feb. 22, 2024, 6:35 p.m. |
|
Horton Amy
VP, Chief Accounting Officer
|
Sale | 1329 | Feb 20, 2024 | Feb. 22, 2024, 6:35 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 2060 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
Davis John E
Chief Commercial Officer
|
Sale | 496 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
Maney Rochelle L.
VP, Quality
|
Sale | 407 | Feb 20, 2024 | Feb. 22, 2024, 6:29 p.m. |
|
Getz Matthew A
VP, Human Resources
|
Sale | 366 | Feb 20, 2024 | Feb. 22, 2024, 6:26 p.m. |